Lufuradom
From Wikipedia, the free encyclopedia
Jump to: navigation, search
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
N-[(8-fluoro-1-methyl-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-yl)methyl]-3-furamide
|
|
| Identifiers | |
| CAS Number | 85118-42-9 |
| ATC code | None |
| PubChem | CID 3045400 |
| ChemSpider | 2308141 |
| Chemical data | |
| Formula | C22H20FN3O2 |
| Molar mass | 377.412 g/mol |
| 3D model (Jmol) | Interactive image |
|
|
|
|
Lufuradom (INN) is a drug and benzodiazepine derivative which, unlike other benzodiazepines, is described as an analgesic.[1] Similarly to its analogue tifluadom, it was never marketed.
See also[edit]
- Tifluadom
- GYKI-52895, structural benzodiazepine which is a dopamine reuptake inhibitor without GABAergic function
- GYKI-52,466, structural benzodiazepine which is an AMPAkine and glutamate antagonist without GABAergic function
References[edit]
- ^ World Health Organization (31 December 1988). International nonproprietary names (INN) for pharmaceutical substances, 1988: lists 1-58 of proposed INN and lists 1-27 of recommended INN : cumulative list. World Health Organization. p. 252. ISBN 978-92-4-056014-7. Retrieved 26 April 2012.
| Opioids | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Paracetamol-type | |||||||||||||||||||||||||||||||
| NSAIDs |
|
||||||||||||||||||||||||||||||
| Cannabinoids | |||||||||||||||||||||||||||||||
| Ion channel modulators |
|
||||||||||||||||||||||||||||||
| Myorelaxants | |||||||||||||||||||||||||||||||
| Others | |||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
 |
This analgesic-related article is a stub. You can help Wikipedia by expanding it. |
Retrieved from "https://en.wikipedia.org/w/index.php?title=Lufuradom&oldid=747043946"
Hidden categories:
